UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Predictors of short-term and long-term mortality in critically ill patients admitted to the intensive care unit following allogeneic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2019-03, Vol.54 (3), p.418-424

2019

Volltextzugriff (PDF)

Ektacytometry Analysis of Post-splenectomy Red Blood Cell Properties Identifies Cell Membrane Stability Test as a Novel Biomarker of Membrane Health in Hereditary Spherocytosis

Frontiers in physiology, 2021-03, Vol.12, p.641384-641384

2021

Volltextzugriff (PDF)

Sickle cell disease: Clinical presentation and management of a global health challenge

Blood reviews, 2019-09, Vol.37, p.100580-100580, Article 100580

2019

Volltextzugriff (PDF)

Pythons and a palmar rash

Netherlands journal of medicine, 2012-06, Vol.70 (5), p.230, 233-233

2012

Volltextzugriff (PDF)

P1501: FOLLOW‐UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE CELL DISEASE

HemaSphere, 2022-06, Vol.6 (Suppl), p.1382-1383

2022

Volltextzugriff (PDF)

P1065: CONGENITAL ERYTHROCYTOSIS DUE TO HETEROZYGOUS VARIANTS IN THE BISPHOSPHOGLYCERATE MUTASE GENE

HemaSphere, 2022-06, Vol.6 (Suppl), p.955-956

2022

Volltextzugriff (PDF)

P1735: IMPROVEMENTS IN PATIENT‐REPORTED OUTCOMES IN MITAPIVAT‐TREATED PATIENTS WITH PYRUVATE KINASE DEFICIENCY: A DESCRIPTIVE ANALYSIS FROM THE PHASE 3 ACTIVATE TRIAL

HemaSphere, 2022-06, Vol.6 (Suppl), p.1616-1617

2022

Volltextzugriff (PDF)

Venous thromboembolism and prothrombotic parameters in Klippel-Trenaunay syndrome

Netherlands journal of medicine, 2013-06, Vol.71 (5), p.246-252

2013

Volltextzugriff (PDF)

P1542: COMORBIDITIES AND COMPLICATIONS ACROSS GENOTYPES IN ADULT PATIENTS WITH PYRUVATE KINASE DEFICIENCY: ANALYSIS FROM THE PEAK REGISTRY

HemaSphere, 2022-06, Vol.6 (Suppl), p.1423-1424

2022

Volltextzugriff (PDF)

P1562: CHARACTERIZING IRON OVERLOAD BY AGE IN PATIENTS DIAGNOSED WITH PYRUVATE KINASE DEFICIENCY – A DESCRIPTIVE ANALYSIS FROM THE PEAK REGISTRY

HemaSphere, 2022-06, Vol.6 (Suppl), p.1443-1444

2022

Volltextzugriff (PDF)

P1565: MITAPIVAT IMPROVES INEFFECTIVE ERYTHROPOIESIS AND REDUCES IRON OVERLOAD IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY

HemaSphere, 2022-06, Vol.6 (Suppl), p.1446-1447

2022

Volltextzugriff (PDF)

P1548: LONG‐TERM TREATMENT WITH ORAL MITAPIVAT IS ASSOCIATED WITH NORMALIZATION OF HEMOGLOBIN LEVELS IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY

HemaSphere, 2022-06, Vol.6 (Suppl), p.1429-1430

2022

Volltextzugriff (PDF)

P1545: DURABILITY OF HEMOGLOBIN RESPONSE AND REDUCTION IN TRANSFUSION BURDEN IS MAINTAINED OVER TIME IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY TREATED WITH MITAPIVAT IN A LONG‐TERM EXTENSION STUDY

HemaSphere, 2022-06, Vol.6 (Suppl), p.1426-1427

2022

Volltextzugriff (PDF)

P1544: BONE MINERAL DENSITY REMAINS STABLE IN PYRUVATE KINASE DEFICIENCY PATIENTS RECEIVING LONG‐TERM TREATMENT WITH MITAPIVAT

HemaSphere, 2022-06, Vol.6 (Suppl), p.1425-1426

2022

Volltextzugriff (PDF)

No association of the hypercoagulable state with sickle cell disease related pulmonary hypertension

Haematologica (Roma), 2008-05, Vol.93 (5), p.e42-e44

2008

Volltextzugriff (PDF)

Acute sinusitis and blindness as the first presentation of chronic lymphocytic leukaemia

Netherlands journal of medicine, 2014-12, Vol.72 (10), p.548-550

2014

Volltextzugriff (PDF)

Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease

Haematologica (Roma), 2009-11, Vol.94 (11), p.1513-1519

2009

Volltextzugriff (PDF)

Do NSAIDs Actually Protect Against Myocardial Infarction and Death?

Clinical pharmacology and therapeutics, 2009-12, Vol.86 (6), p.601-602

2009

Volltextzugriff (PDF)

Back to base pairs: What is the genetic risk for red bloodcell alloimmunization?

Blood reviews, 2021-07, Vol.48, p.100794-100794, Article 100794

2021

Volltextzugriff (PDF)

Use of the oxygen gradient ektacytometry in the dose titration of hydroxyurea therapy in children with sickle cell disease

International journal of laboratory hematology, 2024-04, Vol.46 (2), p.390-394

2024

Volltextzugriff (PDF)

Sickle cell disease-related organ damage occurs irrespective of pain rate: implications for clinical practice

Haematologica (Roma), 2008-05, Vol.93 (5), p.757-760

2008

Volltextzugriff (PDF)

Patient‐controlled analgesia versus continuous infusion of morphine during vaso‐occlusive crisis in sickle cell disease, a randomized controlled trial

American journal of hematology, 2007-11, Vol.82 (11), p.955-960

2007

Volltextzugriff (PDF)

Association of asymmetric dimethylarginine with sickle cell disease-related pulmonary hypertension

Haematologica (Roma), 2008-09, Vol.93 (9), p.1410-1412

2008

Volltextzugriff (PDF)

Sickle cell patients are characterized by a reduced glycocalyx volume

Haematologica (Roma), 2008-02, Vol.93 (2), p.307-308

2008

Volltextzugriff (PDF)

Comment on: Kretowski et al. (2007) Polymorphisms of the renin-angiotensin system genes predict progression of subclinical coronary atherosclerosis: Diabetes 56:863-871

Diabetes (New York, N.Y.), 2007-07, Vol.56 (7), p.e5; author reply e6-e5

2007

Volltextzugriff (PDF)

1 – 25 von 385

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(341)
Mit Volltextzugriff
(316)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(251)
Life Sciences & Biomedicine
(235)
Humans
(201)
Male
(112)
Female
(104)
Adult
(86)
Middle Aged
(81)
Biological And Medical Sciences
(76)
Medical Sciences
(70)
Aged
(55)
Radiology, Nuclear Medicine & Medical Imaging
(48)
Hematology
(37)
General & Internal Medicine
(29)
Magnetic Resonance Imaging
(28)
Oncology
(28)
Adolescent
(27)
Animals
(27)
Respiratory System
(26)
Prospective Studies
(24)
Contrast Media
(22)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Predictors of short-term and long-term mortality in critically ill patients admitted to the intensive care unit following allogeneic stem cell transplantation

Ektacytometry Analysis of Post-splenectomy Red Blood Cell Properties Identifies Cell Membrane Stability Test as a Novel Biomarker of Membrane Health in Hereditary Spherocytosis

Sickle cell disease: Clinical presentation and management of a global health challenge

Pythons and a palmar rash

P1501: FOLLOW‐UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE CELL DISEASE

P1065: CONGENITAL ERYTHROCYTOSIS DUE TO HETEROZYGOUS VARIANTS IN THE BISPHOSPHOGLYCERATE MUTASE GENE

P1735: IMPROVEMENTS IN PATIENT‐REPORTED OUTCOMES IN MITAPIVAT‐TREATED PATIENTS WITH PYRUVATE KINASE DEFICIENCY: A DESCRIPTIVE ANALYSIS FROM THE PHASE 3 ACTIVATE TRIAL

Venous thromboembolism and prothrombotic parameters in Klippel-Trenaunay syndrome

P1542: COMORBIDITIES AND COMPLICATIONS ACROSS GENOTYPES IN ADULT PATIENTS WITH PYRUVATE KINASE DEFICIENCY: ANALYSIS FROM THE PEAK REGISTRY

P1562: CHARACTERIZING IRON OVERLOAD BY AGE IN PATIENTS DIAGNOSED WITH PYRUVATE KINASE DEFICIENCY – A DESCRIPTIVE ANALYSIS FROM THE PEAK REGISTRY

P1565: MITAPIVAT IMPROVES INEFFECTIVE ERYTHROPOIESIS AND REDUCES IRON OVERLOAD IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY

P1548: LONG‐TERM TREATMENT WITH ORAL MITAPIVAT IS ASSOCIATED WITH NORMALIZATION OF HEMOGLOBIN LEVELS IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY

P1545: DURABILITY OF HEMOGLOBIN RESPONSE AND REDUCTION IN TRANSFUSION BURDEN IS MAINTAINED OVER TIME IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY TREATED WITH MITAPIVAT IN A LONG‐TERM EXTENSION STUDY

P1544: BONE MINERAL DENSITY REMAINS STABLE IN PYRUVATE KINASE DEFICIENCY PATIENTS RECEIVING LONG‐TERM TREATMENT WITH MITAPIVAT

No association of the hypercoagulable state with sickle cell disease related pulmonary hypertension

Acute sinusitis and blindness as the first presentation of chronic lymphocytic leukaemia

Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease

Do NSAIDs Actually Protect Against Myocardial Infarction and Death?

Back to base pairs: What is the genetic risk for red bloodcell alloimmunization?

Use of the oxygen gradient ektacytometry in the dose titration of hydroxyurea therapy in children with sickle cell disease

Sickle cell disease-related organ damage occurs irrespective of pain rate: implications for clinical practice

Patient‐controlled analgesia versus continuous infusion of morphine during vaso‐occlusive crisis in sickle cell disease, a randomized controlled trial

Association of asymmetric dimethylarginine with sickle cell disease-related pulmonary hypertension

Sickle cell patients are characterized by a reduced glycocalyx volume

Comment on: Kretowski et al. (2007) Polymorphisms of the renin-angiotensin system genes predict progression of subclinical coronary atherosclerosis: Diabetes 56:863-871

Suchergebnisse filtern